IO Biotech

About IO Biotech

IO Biotech is a pioneering biotechnology company focused on developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines with the mission to improve outcomes for people with melanoma and other tumor types. Their goal is to establish their investigational T-win® vaccines as the backbone of combination therapy for cancer patients.

Products & Services

T-win® Cancer Vaccines:Immune-modulatory, off-the-shelf therapeutic cancer vaccines designed to kill tumor cells and immune-suppressive cells in the tumor microenvironment (TME) by stimulating T cells against IDO1+ and/or PD-L1+ cells, enhancing anti-tumor activity.

Specialties

Immune-modulatory cancer vaccines Tumor microenvironment modulation Clinical immune oncology Translational oncology research

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 57500000 MR: - FA: up to €57.5 million FAN: 57500000	D: 2024-12-20 FD: 2024-12-20	1 investors
2	RT: Private Placement T: - FT: Private Placement	A: 75000000 MR: - FA: $75 million FAN: 75000000	D: 2023-08-07 FD: 2023-08-07	16 investors

Debt Latest

2024-12-20

$57.5M

1 investor (Pro only)

Private Placement 2023-08-07

$75.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Anita Vedel Christiansen

Senior Director, Clinical Operations

I

Inés Lecoq Molinos

Industry Ph.D. Student

J

Joanne Mossucco

Head of Vendor Management

S

Steinn Thorkelsson

Business Controller

M

Mads Hald Andersen

Co-Founder, Scientific Advisor

F

Faiçal Miyara

Chief Business Officer

View 24 more team members with Pro

Unlock Full Team Directory

Recent News

IO Biotech Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised